IMPACT Accelerator Pilot Group
Bowen Therapeutics, Inc.
Bowen Therapeutics is engaged in developing proteins and antibodies to be used as diagnostics or therapeutics to fight against infectious diseases and cancer
Cognita Labs is a respiratory devices innovator that has developed and received FDA clearances for two breakthrough device innovations for pulmonary assessment and medication management
Gel4Med is an early stage regenerative medicine company focused on developing our Therapeutic Materials Platform to address unmet clinical needs in soft tissue regeneration.
Leuko, the first noninvasive white blood cell monitoring device, working to improve quality of life and outcomes for cancer patients on chemotherapy.
LivOnyx is developing a rapid, fully automated hand sanitization system to reduce the spread of resistant bacteria, viruses, Clostridioides difficile spores and more, using its patented thinSpray technology and antiseptic, LVNX- 001.
RegenX LLC is developing a novel collagen technology that can be applied to a variety of dermatology and wound care applications.
Versatope is a biotechnology company harnessing its proprietary probiotic extracellular vesicle platform to develop first in class therapeutics for infectious disease and pan-strain influenza and coronavirus vaccines.
Yocto is using an AI-enabled optical platform for molecular profiling/diagnostics, that can detect infectious pathogens and has the potential to detect cancer cells and help in the administration of personalized treatment.
Young BioPharma is a biopharmaceutical company focused on developing revolutionary therapies that restore function and improve the lives of people with pain, other neurological disorders and cancer.